Study identifier:RO-2455-402-IT
ClinicalTrials.gov identifier:NCT02100332
EudraCT identifier:N/A
CTIS identifier:N/A
Prevalence of Comorbidities of COPD in the Exacerbator Phenotype - A Cross Sectional Disease/Condition Focused Observational Study on COPD
Chronic Obstructive Pulmonary Disease
-
No
-
All
860
Observational
45 Years - 85 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2016 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Chronic obstructive pulmonary disease Patients with chronic obstructive pulmonary disease will undergo a single visit with the collection of data from his/her records. | - |